Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users
E Wood, T Kerr, W Small, K Li, DC Marsh… - Cmaj, 2004 - Can Med Assoc
Background: North America's first medically supervised safer injecting facility for illicit injection
drug users was opened in Vancouver on Sept. 22, 2003. Although similar facilities exist in …
drug users was opened in Vancouver on Sept. 22, 2003. Although similar facilities exist in …
Effect of drug law enforcement on drug market violence: A systematic review
…, G Rowell, G Guyatt, T Kerr, J Montaner, E Wood - International Journal of …, 2011 - Elsevier
Violence is amongst the primary concerns of communities around the world and research has
demonstrated links between violence and the illicit drug trade, particularly in urban settings…
demonstrated links between violence and the illicit drug trade, particularly in urban settings…
The public health and social impacts of drug market enforcement: A review of the evidence
T Kerr, W Small, E Wood - International journal of drug policy, 2005 - Elsevier
The primary response to the harms associated with illicit injection drug use in most settings
has involved intensifying law enforcement in an effort to limit the supply and use of drugs. …
has involved intensifying law enforcement in an effort to limit the supply and use of drugs. …
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
Continuing expansion of the HIV/AIDS pandemic has been recognised as an exceptional
challenge to global health, international development, and world security. UNAIDS estimates …
challenge to global health, international development, and world security. UNAIDS estimates …
Advancing patient‐centered care for structurally vulnerable drug‐using populations: a qualitative study of the perspectives of people who use drugs regarding the …
Aims To explore the perspectives of structurally vulnerable people who use drugs (PWUD)
regarding: (1) the potential integration of harm reduction interventions (eg supervised drug …
regarding: (1) the potential integration of harm reduction interventions (eg supervised drug …
Do supervised injecting facilities attract higher-risk injection drug users?
E Wood, MW Tyndall, K Li, E Lloyd-Smith… - American journal of …, 2005 - Elsevier
BACKGROUND: In Western Europe and elsewhere, medically supervised safer injection
facilities (SIFs) are increasingly being implemented for the prevention of health- and community-…
facilities (SIFs) are increasingly being implemented for the prevention of health- and community-…
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
ContextCurrent recommendations for initiation of antiretroviral therapy in patients infected
with human immunodeficiency virus type 1 (HIV) are based on CD4 T-lymphocyte cell counts …
with human immunodeficiency virus type 1 (HIV) are based on CD4 T-lymphocyte cell counts …
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based …
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood… - The Lancet, 2010 - thelancet.com
Background Results of cohort studies and mathematical models have suggested that
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study
Background Overdose from illicit drugs is a leading cause of premature mortality in North
America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users …
America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users …
Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 …
E Wood, RS Hogg, B Yip, PR Harrigan… - Annals of internal …, 2003 - acpjournals.org
Background: The safety of delaying highly active antiretroviral therapy (HAART) in HIV-infected
patients is uncertain when the CD4+ cell count declines below 0.350 × 10 9 cells/L. …
patients is uncertain when the CD4+ cell count declines below 0.350 × 10 9 cells/L. …